LIVE MARKET TRACKER :   BSE SENSEX   31698.55      |    NSE NIFTY 9884.75    
GLOBAL MARKETS :  NASDAQ 6426.922   +0.066%    |    FSI London 7310.64   +0.64%    |    NIKKEI Japan 20388.61   +0.45%
  USD GBP EUR CAD AUD INR
USD - 0.7390 0.8381 1.2330 1.2565 64.7700
GBP 1.3531 - 1.1340 1.6684 1.7000 87.6348
EUR 1.1935 0.8821 - 1.4716 1.4994 77.2951
CAD 0.8112 0.5999 0.6797 - 1.0194 52.5520
AUD 0.7960 0.5884 0.6671 0.9815 - 51.5530
INR 0.0154 0.0114 0.0129 0.0191 0.0194 -
Indian-Commodity  :  Corporate  :  Cadila Healthcare reports 65% fall in Q1 consolidated net profit

Cadila Healthcare reports 65% fall in Q1 consolidated net profit (11-Aug-2017)

Cadila Healthcare has reported results for first quarter ended June 30, 2017. 

The company has reported a fall of 29.91% in its net profit after tax, Non-Controlling Interests and Share of Profits of joint ventures at Rs 91.40 crore for the quarter under review as compared to Rs 130.40 crore for the same quarter in the previous year. However, total income of the company increased by 13.44% at Rs 1107.40 crore for Q1FY18 as compared Rs 976.20 crore for the corresponding quarter previous year.  

On the consolidated basis, the company has reported a fall of 65.26% in its net profit after tax, Non-Controlling Interests and Share of Profits of joint ventures at Rs 138.40 crore for the quarter under review as compared to Rs 398.40 crore for the same quarter in the previous year. Total income of the company decreased by 4.20% at Rs 2249.80 crore for Q1FY18 as compared Rs 2348.40 crore for the corresponding quarter previous year.


Top News Today
Zydus Cadila, Oberoi Realty and Artefact Projects to see some action today
(25-Sep-2017)

Zydus Cadila, Oberoi Realty and Artefact Projects to see some action todayZydus Cadila has received the final approval from the USFDA to market Amlodipine and Olmesartan Medoxomil Tablets in strengths of 5 mg/20 mg, 5 mg/40 mg 10 mg/20 mg, and 10 mg/40 mg. The drug is indicated......click on news to read complete article.

REC gets nod to raise Rs 65,000 crore via bonds
(23-Sep-2017)

REC gets nod to raise Rs 65,000 crore via bondsRural Electrification Corporation (REC) has received shareholders' approval to raise up to Rs 65,000 crore via bonds over the next one year. The special resolution was passed at the company's annual general......click on news to read complete article.

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.com
(23-Sep-2017)

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.comBNP Paribas Arbitrage has sold 1.40 lakh shares of Matrimony.com. The fund house has offloaded the same at Rs 817.73 on the NSE on September 22, 2017.Recently, BNP Paribas Arbitrage has offloaded 1,34,102......click on news to read complete article.

International Stock News
US markets end flat on geopolitical concerns
(23-Sep-2017)

US markets end flat on geopolitical concernsThe US markets ended the lackluster session near their neutral lines on Friday on geopolitical concerns amid an escalating war of words between North Korean leader Kim Jong Un and President Donald Trump.......click on news to read complete article.

Asian markets trade lower on heightened geopolitical tensions
(22-Sep-2017)

Asian markets trade lower on heightened geopolitical tensionsThe Asian markets are showing a weak trend on Friday, on renewed geopolitical worries after a report that North Korea could respond to fresh sanctions with a hydrogen bomb in the Pacific. A news report......click on news to read complete article.

US markets closed lower; Dow snaps nine-day winning streak
(22-Sep-2017)

US markets closed lower; Dow snaps nine-day winning streakThe US markets closed lower on Thursday, with the Dow snapping a nine-day winning streak as investors found few reasons to chase equities a day after the Federal Reserve indicated it still intends to deliver......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.